14 August 2026
FDA clears tau PET tracer TAUKLARIFY
Florquinitau F 18 (MK-6240) is indicated to identify tau NFT pathology in cognitively impaired adults being evaluated for Alzheimer’s disease.
The full briefing is in the app.
14 August 2026
Florquinitau F 18 (MK-6240) is indicated to identify tau NFT pathology in cognitively impaired adults being evaluated for Alzheimer’s disease.
The full briefing is in the app.